Welcome to Startups Weekly — a weekly roundup of must-sees from the world of startups. Sign up here to get it delivered to your inbox every Friday.
After years of rapid growth, the AI industry is now seeing a significant slowdown in investment, as detailed in a recent report from Stanford University's Human Centered Artificial Intelligence Institute (HAI). The report highlights a significant decline in private and corporate investment in AI for the second year in a row, with overall investment expected to decline by 20% year-on-year in 2023. He reports. Despite this overall downturn, certain segments, such as generative AI, continue to attract significant funding, showing selective and significant interest in specific AI applications.
Investment in AI has slowed for several reasons, including market congestion and the rising cost of building large-scale AI models. According to Gartner analyst John-David Lovelock, money is now flowing more to large established companies that are consolidating their positions, but new entrants are increasingly getting a piece of the pie. It is said that it is becoming difficult. Investors are becoming increasingly selective, looking for real, solid returns rather than just throwing money at promising growth. (Of course, that doesn't stop billions of dollars in AI-focused funding.)
Despite these hurdles, there remains strong belief in the future of AI, especially its potential to increase efficiency and spark innovation across a variety of sectors. The market is now consolidating a bit, moving from the wild spending of the past to more thoughtful and sustainable funding methods. This shift is key to creating AI solutions that actually work in the real world, truly transform industries, and bite into our battle-weary minds.
Oh, and before I pile on the rest of the startup news this week… Do you have a pitch deck that would be suitable for my Pitch Deck Deconstruction series? You can submit it here. We'd love to take a closer look and share our detailed review with TechCrunch readers.
This week's most interesting startup stories
hey hey! look!It is the triumphant return of TechCrunch veteran Anthony Hawrites that Airchat, the latest brainchild of Naval Ravikant and Brian Norgard, will revolutionize social media with its groundbreaking concept of letting people talk to each other. Shocking, right? This app is essentially a high-tech walkie-talkie that lets you follow other people, scroll through your feed, and interact with audio posts. Audio posts are also conveniently transcribed for those who don't like human voices. It's currently climbing the social ladder in the App Store, and while it's invite-only, it's because nothing screams exclusivity more than needing a golden ticket to listen to a stranger's chit-chat. It remains to be seen whether this will actually reduce online fighting or just make it more melodic.
Airchat is like a tech-centric coffee shop where everyone is buzzing about the latest in Silicon Valley, and it even has a transcription feature that lets you get accurate Pokemon names. Because it is a high priority. But don't get too excited. It's invite-only, making it another Silicon Valley whisper network. And while it's all fun audio gaming, the platform's laid-back approach to content moderation can make it a wild west of voice chat where the only sheriff in town is a mute button.
Noname lost her unicorn horn. Noname Security, the cybersecurity startup he once strutted around with a $1 billion valuation, is now whispering sweet nothings to Akamai Technologies for his even more modest $500 million. Masu. Hey, where's my phone? In a world where your smartphone feels like an extension of your hand, Humane is touting Ai Pin, a $699 wearable that promises to be the next big thing. Hardware Editor Brian takes a deep dive into the place. Where did the company come from and where is it going from here? Defeating an army of bots: Betaworks is diving headfirst into his AI pool, but instead of reusing the big LLMs, it's floating new ideas. It's an AI agent designed to tackle mundane tasks that we hate. They want to hatch nine of these digital minions from a state-of-the-art “camp” incubator and automate everything from sorting emails to scheduling meetings.
This week's most interesting fundraisers
Ripling, the darling of the HR tech world that has been siphoning off venture capital like it was obsolete, is at it again. This time, they're circulating Silicon Valley's collection plates for $200 million in new capital, while simultaneously cashing out as much as $670 million in cash to current shareholders. This latest funding fest, called Series F, could boost Rippling's valuation to a staggering $13.4 billion. Not too shabby for a company whose CEO, Parker Conrad, frantically tweeted and made phone calls last year in the wake of the Silicon Valley Banking meltdown to scrape together a paycheck. do not have. Now, with everyone writing record-breaking checks (and Courtier leading the round), Rippling seems more focused on making waves than making waves.
Rapid growth: Ramp, a spend management startup clearly focused on profitability, just raised another $150 million to keep the lights on and acquisitions moving forward. Now valued at $7.7 billion, Rump is playing financial Tetris with a mix of old and new investors, including a star-studded lineup of Khosla Ventures, Founders Fund, and Sequoia Capital. Why do you think that is? Twochairs, a therapy startup that once championed the exotic concept of “real human interaction,” has succumbed to the digital wave and replaced its stylish clinic with Zoom rooms. Ta. The company, which just received a $72 million cash infusion, plans to continue expanding its digital footprint. Finding the right therapist online is still as difficult as a Sudoku puzzle, but at least you don't have to leave your couch to be disappointed. Dust it off and try again. Livos, the semiconductor startup that Apple once accused of using trade secrets to “catch me if you can,” somehow managed to turn a courtroom melodrama into a $250 million fundraising fest. succeeded in. Even after the Apple lawsuit drama subsided, Ribos didn't just walk away. They rushed back to the lab to produce chips that could potentially benefit iPhone makers.
Other must-see TechCrunch articles…
Every week, we have a few stories that just don't fit into the categories above, but we'd like to share with you. It would be a shame if you missed it, so I'd like to introduce you to a random bag containing goodies.
You've been hacked: Apple is playing digital knight in shining armor by bombarding iPhone users in 92 countries with 'You may have been hacked' notifications . This isn't your typical phishing scam, but a full-fledged spyware drama featuring shadowy attackers and maybe even a cameo from the infamous Pegasus spyware. Tesla cuts jobs: In a typical pre-earnings panic move, Tesla has decided to thin the group by laying off 14,000 employees, including some of its star players. Apparently, the electric vehicle giant is feeling threatened by the ongoing EV price war and is prompting a “company-wide restructuring,” perhaps to increase productivity and prepare for the “next phase of growth.” . This corporate euphemism means cutting out even the best talent, especially those unlucky enough to work on lower priority projects. Reinventing humanoid robotics: A day after discontinuing hydraulic models, the CEO of Boston He Dynamics talks about the company's commercial humanoid ambitions with electric options. Continuing to destroy Twitter: In latest effort to save his corner of the internet, Elon Musk says the best way to combat X's bot infestation is to attack new users where it hurts: their wallets. I decided that it was the right thing to do. For a small, undisclosed fee, you too can prove your humanity and earn the privilege of posting on the platform. Hello, is there a doctor?: Hug Face is always up for a challenge. This time, the company has decided to tackle the wilds of AI in healthcare with its latest work, his Open Medical LLM. This new benchmark, essentially a Frankenstein's Monster-like piece of existing medical test set, will test whether AI can actually handle the medical big leagues without falsely suggesting headache leeches. It was pieced together to confirm. This is a noble effort to bring standardization to the chaotic field of generative AI, which has been introduced into medical settings with high hopes and expectations.